These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35213375)

  • 1. Sporadic Alzheimer's Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss.
    Tsamou M; Carpi D; Pistollato F; Roggen EL
    J Alzheimers Dis; 2022; 86(3):1427-1457. PubMed ID: 35213375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants.
    Tsamou M; Pistollato F; Roggen EL
    J Alzheimers Dis; 2021; 81(2):459-485. PubMed ID: 33843671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD).
    Tsamou M; Roggen EL
    Brain Res; 2024 Apr; 1829():148791. PubMed ID: 38307153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Candidate microRNA Profile for Early Diagnosis of Sporadic Alzheimer's Disease.
    Tsamou M; Kalligerou F; Ntanasi E; Scarmeas N; Skalicky S; Hackl M; Roggen EL
    J Alzheimers Dis Rep; 2023; 7(1):235-248. PubMed ID: 37090956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lncRNA-ATB prevents amyloid-β-induced neurotoxicity in PC12 cells via regulating miR-200/ZNF217 axis.
    Wang J; Zhou T; Wang T; Wang B
    Biomed Pharmacother; 2018 Dec; 108():707-715. PubMed ID: 30248538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
    Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
    J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
    Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
    Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studying the system-level involvement of microRNAs in Parkinson's disease.
    Chatterjee P; Bhattacharyya M; Bandyopadhyay S; Roy D
    PLoS One; 2014; 9(4):e93751. PubMed ID: 24690883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer's Disease Pathology: Evidence from
    Gupta S; Singh V; Ganesh S; Singhal NK; Sandhir R
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):69-93. PubMed ID: 34967205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease.
    Liu D; Tang H; Li XY; Deng MF; Wei N; Wang X; Zhou YF; Wang DQ; Fu P; Wang JZ; Hébert SS; Chen JG; Lu Y; Zhu LQ
    Mol Ther; 2017 Mar; 25(3):752-764. PubMed ID: 28202389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.
    Ferrer I
    Free Neuropathol; 2022 Jan; 3():. PubMed ID: 37284149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-214-3p attenuates cognition defects via the inhibition of autophagy in SAMP8 mouse model of sporadic Alzheimer's disease.
    Zhang Y; Li Q; Liu C; Gao S; Ping H; Wang J; Wang P
    Neurotoxicology; 2016 Sep; 56():139-149. PubMed ID: 27397902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microRNA-455 Null Mouse Has Memory Deficit and Increased Anxiety, Targeting Key Genes Involved in Alzheimer's Disease.
    Swingler TE; Niu L; Pontifex MG; Vauzour D; Clark IM
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
    Pan K; Chen S; Wang Y; Yao W; Gao X
    Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.
    Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic mice.
    Hernandez-Rapp J; Rainone S; Goupil C; Dorval V; Smith PY; Saint-Pierre M; Vallée M; Planel E; Droit A; Calon F; Cicchetti F; Hébert SS
    Sci Rep; 2016 Aug; 6():30953. PubMed ID: 27484949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.
    Bal-Price A; Meek MEB
    Pharmacol Ther; 2017 Nov; 179():84-95. PubMed ID: 28529068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer's Disease.
    Wang X; Liu D; Huang HZ; Wang ZH; Hou TY; Yang X; Pang P; Wei N; Zhou YF; Dupras MJ; Calon F; Wang YT; Man HY; Chen JG; Wang JZ; Hébert SS; Lu Y; Zhu LQ
    Biol Psychiatry; 2018 Mar; 83(5):395-405. PubMed ID: 28965984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.